Treatment of Acute Migraine when Pain is Mild versus when Pain is Moderate to Severe an Almotriptan Parallel, Placebo Controlled Clinical Trial. Act when mild

• Conditions: Treatment of acute migraine; MedDRA version: 6.1Level: PTClassification code 10027599

• Registration Number: EUCTR2004-005285-20-IT
• Lead Sponsor: ALMIRALL PRODESFARMA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-01-03
• Last Update Posted: 1 May 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: ;Secondary Objective: ;Primary end point(s):